Drugging the intrinsically disordered transactivation domain of androgen receptor
Artículo
Acceso abierto
Artículo
DOAJ
Abstract Androgen receptor (AR) is a therapeutic target for prostate cancer. Despite effectively targeting its folded ligand-binding domain (LBD), resistance ultimately develops by mechanisms involving reactivation of AR...
LCC LCC:Medicine; LCC:Biology (General)Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access